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Abstract
Background: Capparis Spinosa L. is an aromatic plant growing wild in dry regions around the Mediterranean basin.
Capparis Spinosa was shown to possess several properties such as antioxidant, antifungal, and anti-hepatotoxic
actions. In this work, we aimed to evaluate immunomodulatory properties of Capparis Spinosa leaf extracts in vitro
on human peripheral blood mononuclear cells (PBMCs) from healthy individuals.
Results: Using MTT assay, we identified a range of Capparis Spinosa doses, which were not toxic. Unexpectedly, we
found out that Capparis Spinosa aqueous fraction exhibited an increase in cell metabolic activity, even though
similar doses did not affect cell proliferation as shown by CFSE. Interestingly, Capparis Spinosa aqueous fraction
appeared to induce an overall anti-inflammatory response through significant inhibition of IL-17 and induction of
IL-4 gene expression when PBMCs were treated with the non toxic doses of 100 and/or 500 μg/ml. Phytoscreening
analysis of the used Capparis Spinosa preparations showed that these contain tannins; sterols, alkaloids; polyphenols and
flavonoids. Surprisingly, quantification assays showed that our Capparis Spinosa preparation contains low amounts of
polyphenols relative to Capparis Spinosa used in other studies. This Capparis Spinosa also appeared to act as a weaker
scavenging free radical agent as evidenced by DPPH radical scavenging test. Finally, polyphenolic compounds including
catechin, caffeic acid, syringic acid, rutin and ferulic acid were identified by HPLC, in the Capparis spinosa preparation.
Conclusion: Altogether, these findings suggest that our Capparis Spinosa preparation contains interesting compounds,
which could be used to suppress IL-17 and to enhance IL-4 gene expression in certain inflammatory situations. Other
studies are underway in order to identify the compound(s) underlying this effect.
Keywords: Capparis Spinosa, Peripheral blood mononuclear cells, Anti-inflammation, Cytokines, Gene expression, Cell
proliferation, Cell viability
Background
Among Peripheral Blood Mononuclear Cells (PBMCs),
there are Monocytes, Natural Killer cells, B cells and T
cells. Naïve CD4+ T cells can differentiate into several
distinct subpopulations including Th1, Th2 and Th17
cells. Identification of these T cells subsets is based
mainly on their immunological functions that are sup-
ported by the specific cytokines these different cells pro-
duce. Th1 cells are characterized by high secretion of
IFN-γ and IL-2. These cells are responsible for intracel-
lular pathogen elimination [1]; but are also involved in
the development of organ-specific autoimmune diseases,
as well as chronic inflammatory disorders [2]. Th2 cells
are implicated in humoral immunity and provide protec-
tion against parasites. They also play a major role in the
initiation, maintenance, and amplification of human al-
lergic inflammation [3]. Th2 cells produce IL-4, IL-10
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and IL-13, which are involved in allergic asthma [3, 4].
Th17 cells produce mainly IL-17A and IL-17F and take
a major part in the clearance of extracellular bacteria
and fungi, due to their capacity to recruit and activate
Neutrophils [5]. In contrast, they promote the pathogen-
esis of cancer [6], several autoimmune and inflammatory
diseases [7], such as multiple sclerosis, rheumatoid arth-
ritis, inflammatory bowel disease, psoriasis and contact
dermatitis [8, 9]. New compounds could have a great
interest, in several pathophysiological situations such as
autoimmunity [7] and cancer [6], if they are able to sup-
press the expression of pro-inflammatory cytokines such
as IL-17. These molecules could be synthetic or natural,
extracted from plants.
Capparis Spinosa L. (C.S.) is an aromatic plant grow-
ing wild in dry regions around the Mediterranean basin
[10, 11]. Different parts of this plant, including the
flower buds, fruits, seeds, and roots, were traditionally
used in folk medicine to treat rheumatism, digestive
problems, headaches, and toothaches. C.S. was also used
as a diuretic, antihypertensive and tonic [10, 12, 13]. It has
also been shown that C.S. extracts possess several bioac-
tivities such as antioxidant, antifungal, anti-hepatotoxic
and anti-inflammatory actions [14, 15]. Reports showed
that C.S. contains alkaloids, lipids, polyphenols, flavonoids,
indole and aliphatic glucosinolates [16, 17]; which are
known to possess bioactive properties.
Specific T cell subsets could be stimulated to produce
specific cytokines after their interaction with different
natural or synthetic molecules and cytokines [18–20].
Their specific cytokines initiate and orientate the im-
mune response. On this basis, they are divided into pro-
inflammatory (e.g., IL-17, INF-γ, TNF-α) and anti-
inflammatory (e.g., IL-4, IL-10, TGF-β) cytokines. Here,
we aimed to evaluate potential anti-inflammatory prop-
erties of C.S. leaves on human peripheral blood mono-
nuclear cells. Our data indicate that, doses of C.S.
extracts, which are not toxic and do not affect cell
proliferation, are able to suppress pro-inflammatory
cytokines such as IL-17 and promote expression of
anti-inflammatory cytokines such as IL-4. C.S. may
therefore contain compounds that could be used as
anti-inflammatory in certain pathophysiological situations.
Studies are in progress in order to identify these
compounds.
Results
Cell viability and metabolic activity upon treatment with
Capparis Spinosa
In order to test whether C.S. preparations could contain
compounds that have the ability to regulate immune sys-
tem cells and eventually suppress pro-inflammatory cy-
tokines, we started by assessing cell toxicity. Human
PBMCs were incubated with increasing doses of either
C.S. crud extract or the corresponding aqueous fraction,
in the presence or absence of phytohaemagglutinin
(PHA). Our results showed that both C.S. preparations
did not induce cell toxicity, even when used at relatively
high doses (700 μg/ml) (Fig. 1a and c). This absence of
toxicity was observed also when the PHA was added
(Fig. 1 b and d). Interestingly, we noticed unexpected
and significant increase in succinat deshydrogenase (SDH)
enzymatic activity upon PHA stimulation in the presence
of the aqueous (Fig. 1b) but not the crud (Fig. 1d) extract
of C.S. This enhancement of the enzymatic activity of
mitochondrial SDH may reflect an increase in prolifera-
tion and/or other cell function as reported in previous pa-
pers [21, 22]. This effect was more pronounced in the
presence of the aqueous fraction relative to the crud
extract (Fig. 1b and d) and was statistically significant
(Fig. 1b, and Additional file 1).
Cell proliferation upon treatment with Capparis Spinosa
Since C.S. aqueous fraction showed enhanced SDH enzym-
atic activity on PBMCs, we tested whether this could be
related to an enhancement of cell proliferation. To assess
this hypothesis, we used CFSE and flow cytometry. CFSE-
labeled PBMCs were stimulated with PHA in the presence
or absence of different doses of C.S. preparations (crud
extract or aqueous fraction) for 96 h. While CFSE-
labeled, PHA-treated PBMCs showed marked prolifera-
tion compared to control cells (Fig. 2a, b, and o), neither
of the two extracts of C.S. induced proliferation either
alone (Fig. 2f, g, h, i, j, k and n) or in the presence of PHA
(Fig. 2c, d, e, l, m and o, and Additional file 2).
Qualitative phytochemical analysis and antioxidant
activity of Capparis Spinosa
In order to identify potential bio-active chemical classes
present in C.S. extracts, we proceeded to a qualitative
chemical screening. As depicted in Table 1, we found
that our extract contained: tannins, sterols, alkaloids,
polyphenols and flavonoids. Subsequently, we quantified
total polyphenols and total flavonoids in C.S. extract and
found about 0.08247 mg galic acid equivalent /g of dried
extract; and about 0.02129 mg quercitin equivalent /g of
dried extract (Table 2), total flavonoid represents 25.8 %
of total polyphenolic compounds.
On the other hand, antioxidant activity was assessed
using DPPH radical scavenging test. The 50 % inhibition
concentration (IC50) of scavenging free radical effect
was evaluated and found to be 8.27 mg of C.S. crud ex-
tract per ml. This value was far lower than that obtained
with ascorbic acid, used as positive control, known by its
high antioxidant activity (IC50 = 0.100 +/− 0.004 mg/ml
for DPPH) (Fig. 3, and Additional file 3).
The effect of C.S. on pro and anti-inflammatory cyto-
kines was then evaluated using doses of C.S., which were
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found to be not toxic. Figure 4 shows the effect of C.S.
aqueous fraction on the expression of 5 cytokines after
18 h treatment. Data in panel A shows increases in IL-4
gene expression in cells treated with the aqueous frac-
tion of C.S. This increase was, however, statistically sig-
nificant with 100 μg/ml but not with 500 μg/ml of the
aqueous fraction of C.S. This observation suggests that
C.S. promotes induction of the IL-4 known as anti-
inflammatory Th2 cytokine. In Panel B, we found a clear
decrease in IL-17 gene expression when PBMCs were
treated with 500 μg/ml of C.S. aqueous fraction. This de-
crease was statistically significant. In contrast, cells
treated with 100 μg/ml did not show any significant
effect on IL-17 gene expression. These data suggested
that C.S. acts as an anti-inflammatory factor. Indeed,
C.S. consistently promoted IL-4 (an anti-inflammatory
cytokine) and inhibited IL-17 (a pro-inflammatory Th17
cytokine). Regarding IL-10, we did not detect any sig-
nificant effect on PBMCs treated with either 100 or
500 μg/ml of the aqueous fraction of C.S. (Fig. 4
panel c). In fact, we observed a tendency of decrease
using 100 μg/ml, and a tendency of increase at
500 μg/ml of the aqueous fraction of C.S. However,
none of these effects were statistically significant
(Fig. 4 panel c). Tendencies of increases in TGF-β
with both 100 and 500 μg/ml and decreases in TNF-α
were detected. However, these effects were not statistically
significant (Fig. 4, panel d and e, and Additional file 4).
We also tried to quantify the expression of IFN-γ in our
experiments, but we could detect its expression in only
one out of five tested donors; thus no conclusions could
be drawn. When PBMCs were stimulated with PHA and
incubated with C.S. aqueous fraction (Additional file 5:
Figure S1, Panels G, H, I, K and J), we did not detect
any significant effect in C.S.- treated relative to con-
trol cells for any of the cytokines tested, IL-4, IL-17, IL-
10, TGF-β and TNF-α. Altogether our data suggest that
100 μg/ml of C.S. aqueous fraction is efficient and suffi-
cient to affect cytokine gene expression, by stimulating
the expression of anti-inflammatory cytokines namely
IL-4 and TGF-β and inhibiting the expression of pro-
inflammatory cytokine TNF-α. On the other hand, C.S.
a b
c d
Fig. 1 Increasing doses of Capparis Spinosa aqueous fraction enhanced MTT reduction in human PBMCs. Human PBMCs were cultured for 4 days
with or without PHA (5 μg/ml) in the presence of increasing doses of the aqueous fraction or the crud extract of Capparis Spinosa, Panel a: PBMCs
without PHA in the presence of different doses of the aqueous phase of C.S. Panel b: PBMCs stimulated with PHA in the presence of different doses of
the aqueous fraction of C.S. Panel c: PBMCs without PHA in the presence of different doses of the crude extract of C.S. Panel d: PBMCs stimulated with
PHA in the presence of different doses of the crud extract of C.S. Three to five independent experiences were performed. Data were analyzed using
the one-way ANOVA test. (*, **, ***) indicate a P value of less than 0.05; 0.01 and 0.001 respectively
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aqueous fraction at 500 μg/ml showed a clear inhibition
of another pro-inflammatory cytokine, IL-17. These ob-
servations indicate that the C.S. aqueous fraction may
contain compounds endowed with anti-inflammatory
properties.
Analysis of Capparis Spinosa extract by HPLC
In order to identify several known polyphenol and
flavonoid compounds present in our C.S. extract, we
have analyzed it by HPLC at 285 nm, using a mixture
of 7 standards, which are catechin, vanillic acid, caf-
feic acid, syringic acid, rutin, ferulic acid, and vanillin
(Fig. 5a). Five compounds were identified from the
extract by matching their retention times to those of
the standards (Fig. 5b). These compounds are cat-
echin, caffeic acid, syringic acid, rutin and ferulic
acid. Peak assignment was confirmed by injection of
standards.
Discussion
Immunomodulation using medicinal plants (or their
compounds) can provide alternatives to the conventional
therapy for a variety of diseases [23]. It could be effective,
for instance, in cases of immune deficiency, autoimmunity
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Fig. 2 Capparis Spinosa crud extract and aqueous fraction did not affect proliferation of human PBMCs. a CFSE-stained PBMCs stimulated with
PHA 5 μg/ml. b CFSE-stained PBMCs in the absence of stimulation. c, d, and e an example of curves generated by CFSE-stained PBMC, stimulated
with PHA 5 μg/ml and harvested with 10, 100 and 500 μg/ml respectively of aqueous fraction, f, g and h an example of curves generated by
CFSE-stained PBMC harvested with of 10, 100 and 500 μg/ml of aqueous fraction, for 4 days. i, j and k An example of curves generated by proliferation
of CFSE-stained PBMC harvested with 10, 100 and 500 μg/ml of crud extract for 4 days of culture. l and m An example of curves generated by
CFSE-stained and stimulated PBMC in the presence of 10 and 100 μg/ml respectively of the crud extract, for 4 days. n and o Cumulative data
from five independent experiments analyzed statistically using one-way ANOVA test. (***) indicate a P value of less 0.001 respectively. Each peak
represents a cycle cell division. The curves generated by the CFSE profile were analyzed using the proliferation platform of the FlowJo software.
Data shown represent results of five independent experiments
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or cancer to appropriately regulate the immune response
and maintain a disease free state. In this study, we aimed
to decipher immunomodulatory effects of C.S. leaf ex-
tracts on human peripheral blood mononuclear cells using
C.S. plant from Morocco. In order to test whether C.S.
could exhibit potential anti-inflammatory or other benefi-
cial immunomodulatory effects, non toxic doses of C.S.
extracts were determined using MTT assay. Subsequently,
these non toxic doses were used to evaluate the C.S. effect
on cell proliferation using CFSE. Our data revealed that
doses up to 800 μg/ml of C.S. preparations were not toxic
to human PBMCs (Fig. 1). Unexpectedly, we detected an
increase in SDH enzymatic activity using doses of the C.S.
aqueous fraction ranging from 300 to 600 μg/ml (Fig. 1b).
This suggested either enhanced proliferation and/or en-
hanced metabolic activity of cells upon treatment with
C.S. Consistent with our data, similar range of doses from
400 to 600 μg/ml were also shown to be non cytotoxic
when lyophilized extracts of Italian C.S. buds were
used [24].
It has been demonstrated in previous studies, that C.S.
extracts elicit a protective effect in pathological con-
ditions related to the oxidative stress status [14, 25].
This effect is likely due to effective antioxidant/free
radical scavenging properties [25]. Indeed, C.S. was
shown to be rich in polyphenols, which are known to
be effective antioxidant/free radical scavenging com-
pounds [15, 25, 26]. Therefore, we tested whether our
extracts, obtained from the Moroccan C.S. leaves,
could show similar protective effects. In this aspect,
we began with a qualitative screening that confirmed
the presence of flavonoids and polyphenols. Then we
quantified their presence, and found that our C.S. ex-
tract is not as rich in polyphenols as other C.S. ex-
tracts used in other studies and obtained from
different region of the world [10, 13, 15, 25, 27, 28].
In fact, in our extract, total polyphenol content was
0.08247 mg GAE/g of dried extract which is far infer-
ior to Tunisian and Indian C.S. [13, 29]. Comparing
the total polyphenol content of our leaf extract to that of
extracts from other parts of the plant (performed in previ-
ous studies), ours is much lower than Italian C.S. flower
buds [15, 25], Tunisian flower buds [13] and lower than
Bahrainian [28] and Turkish C.S. fruit [27]. On the other
hand, in our C.S. extract, total flavonoid content was
0.02129 mg quercitin equivalent /g of dried leaf extract. In
comparison to other C.S. that are considered as a rich
source of flavonoids, our values appear to be lower than
those of Bahrainian C.S. fruit [28] and those of Indian C.S.
[29]. These variations and differences in total phenol and
flavonoid contents might be explained by geographical
factors and by distinct processing methods. We also
compared the IC50 of the scavenging free radical test
obtained from our study to those obtained in previ-
ous studies. The IC50 of our C.S. leaf extract was
8.27 mg/ml of crud extract, which is similar to the
Bahrainian C.S. fruit [28], and far weaker than the
Italian C.S. bud extracts (0.177 mg of extract/ml)
[25]; 0.068 mg/ml [15, 25] and the Turkish Caper
fruit extract (0.32 mg/ml) [27]. Our C.S. leaf extract
appears also to be by far a weaker scavenging free
radical agent relative to the Indian C.S. leaf extract
(0.073 mg/ml) [29]. Worth specifying that direct com-
parison of data from the current study with those re-
ported in the literature is difficult since different
parts of the plant and different expression units were
used. However, in light of these data, the low anti-oxidant
activity of the Moroccan C.S. leaf crud extract might be
due to low amounts of total polyphenolic and flavonoid
compounds known as effective anti-oxidant molecules.
Table 2 Dosage of polyphenols and flavonoids in Capparis
Spinosa crud extract
Concentration (Mean+ /-SD) Crud extract of
Capparis Spinosa
Polyphenols (mg galic acid equivalent/g) 0,08247+/− 0,001201
Flavonoïds (mg quercitin equivalent/g) 0,02129 +/− 0,0001626
Fig. 3 Capparis spinosa’s low anti-oxidant activity by DPPH Radical
Scavenging test
Table 1 Phytochemical analysis of Capparis Spinosa’s crud
extract and aqueous fraction
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Fig. 4 Effects of Capparis Spinosa’s aqueous fraction on IL-4, IL-17, IL-10, TGF-β and TNF-α expression in PBMCs in culture. a IL-4, b IL-17, c IL-10, d
TGF-β, e TNF − α. Incubated for 18 h, doses used 100 and 500 μg/ml. Data represent the mean ± S.D. Data from n = 5 separate experiments. Data
were analyzed using the one-way ANOVA (Kruskal-Wallis test), flowed by Dunn’s post test (*) indicate a P value of less than 0.05
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Cytokines are key elements of the innate and adaptive
immune response and provide a window through which
diseases can be monitored and eventually controlled
[30]. So we focused on the effects of C.S. extract on
cytokine expression. In our present study, we showed
that the aqueous fraction of C.S. leaf extract seems to
have a modulator effect on IL-4, IL-17 in PBMCs from
healthy donors. This consists of a stimulation of IL-4 ex-
pression (anti-inflammatory cytokine) and an inhibition
of IL-17 expression (pro-inflammatory cytokine). Add-
itionally, we detected a tendency of stimulating TGF-β
expression in parallel with a trend of inhibiting TNF − α
expression in PBMCs treated with C.S. extract though
these effects were not statistically significant in our ex-
periments. Finally, we could not detect consistent ex-
pression of IFN-γ gene in human PBMCs even in the
absence of treatment with C.S. extract. The induction of
IL-4 and the inhibition of IL-17 by C.S. are interesting
since these are anti and pro-inflammatory cytokines,
respectively. IL-4 is produced mainly by Th2 cells
(humoral immunity) and is a primary driver of the Th2
phenotype; it is involved in down regulation of inflam-
matory and Th1-mediated responses [31, 32]. On the
other hand, IL-17 is the hallmark of Th17 cells. It is
considered a major pro-inflammatory cytokine, with
pivotal roles in inflammatory and autoimmune dis-
eases including Rheumatoid Arthritis and Multiple
Sclerosis [33–35]. These data suggest an overall anti-
inflammatory effect of C.S. on the immune response.
Compounds from this plant could eventually play, in
the future, an interesting role in modulating several
pathologies in which IL-17 plays an important task.
For instance, an involvement of IL-17 was also
strongly suggested in tumor development and in both
inflammation and sporadic cancers of the liver, stom-
ach, and colon [36]. In the same time, the interesting
trends observed in our work; increased TGF-β expres-
sion and decreased TNF-α expression in cells treated
with C.S., are consistent with the modulatory effect
observed on IL-4 and IL-17. Indeed, TGF-β is mostly
assigned as an anti-inflammatory cytokine (produced
by Treg cells), which achieves distinct immunosup-
pressive properties on various aspects of the immune
response and also maintain self tolerance [37, 38]. On
the other hand, TNF-α is a major pro-inflammatory
cytokine, which plays relevant roles in pathogenesis of
many autoimmune diseases and stimulates secretion
of other inflammatory cytokines [39]. High levels of
TNF-α are indeed associated with various acute and
chronic inflammatory conditions [40, 41]. Our data seem
to be different from those published in another report [24]
in which C.S. extract failed to induce IL-4 production and
rather up-regulated, pro-inflammatory cytokines (TNF-α
and IFN-γ) in human PBMCs. These effects were attrib-
uted to the richness of Italian C.S. in polyphenols and fla-
vonoids. In our experiments, the tendency of inhibiting
TNF-α expression might be due either to a direct effect of
extract compounds on the signaling cascade leading
to TNF-α expression or to IL-4 induction also known
to inhibit TNF-α [42]. TGF-β, which is an important
Fig. 5 Identification of several polyphenol and flavinoid compounds in Capparis Spinosa extract. a Chromatogram of 7 available polyphenol and
flavonoid standards monitored at 280 nm and identified with retention times (minutes) 1: catechin, 2: vanillic acid, 3: caffeic acid, 4: syringic acid,
5: rutin, 6: ferulic acid, 7: vanillin. b HPLC chromatogram of of Capparis Spinosa extract obtained under optimum conditions: 88 % water and 12 %
acetonitril, 50 min. Peak no. 1: catechin, 3: caffeic acid, 4: syringic acid, 5: rutin and 6: ferulic acid were identified
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anti-inflammatory cytokine, known to antagonize TNF-α
and IFN-γ, was also stimulated by C.S. The overall inhib-
ition of IL-17 and of TNF-α in addition to the stimulation
of IL-4 and TGF-β implies that there might be an en-
hancement of anti-inflammatory cytokine in the account
of pro-inflammatory cytokines.
HPLC analysis of C.S. extract showed the presence of
various bioactive polyphenolic and flavonoid com-
pounds, known for their anticancer potential, anti-
inflammatory and immunomodulatory effects. For in-
stance, Catechin is a flavonoid and a major compound
of the catechines family, which were famous for their
ability to control lymphocyte proliferation and modulate
IL-2 and IFN-γ secretion in human PBMCs and mouse
splenocytes [43]. Data from a previous work showed that
catechin exerts an inhibition of immune activation and a
regulation of unbalanced levels of IL-17/IL-10 [44]. It re-
versed abnormal polarization of Th17 as well as Treg
cells in rat peripheral blood and spleen, by oral adminis-
tration. It suppressed chronic heart failure induced by
abdominal aorta ligation, which was closely associated
with catechin modulation of Th17 and Treg in rats.
With regard to caffeic acid, a derivative of cinnamic
acids which are part of phenolic acids, is structurally
related to flavonoids and is a biologically active compo-
nent. It has been found to possess anti-mitogenic, anti-
inflammatory and immunomodulatory effects [45].
Caffeic acid inhibited colonic IL-17 expression and in-
creased IL-4 expression [46]. It also decreased IL-1β
production by 40 % and did not affect TNF-α and IL-6
in human blood [47]. As for syringic acid, which is from
the same family as the caffeic acid, it was found to sup-
press significantly pro-inflammatory cytokines (IFN-γ,
TNF-α and IL-6) in serum of mice suffering immune-
mediated liver inflammation [48]. Ferulic acid was found
to have a chemopreventive activity against colon and
rectal cancer [49]. As for the compound rutin, also
known as vitamin P, it is a very important plant phenolic
compound because of its anti-inflammatory property
[50]; [51]. Since it was found to be capable of suppress-
ing increased IL-17, and enhancing decreased IL-4 ex-
pressions, a characteristic of dextran sulfate sodium
(DSS)- induced colitis, and presented a partial protection
against DSS-induced colitis in mice [52]. Rutin also,
ameliorated TNBS-induced colitis in rats by inhibiting
TNF-α-induced NF-kB activation [53]. Some reports
also showed that rutin was effective on the chronic
phase of rat adjuvant arthritis [54]. Rutin was found to
possess, in addition to anti-inflammatory potential, an
anti-carcinogenic effect [13, 55].
Conclusion
The anti-inflammatory response obtained on human
PBMCs with Moroccan C.S. preparations suggests a
potential beneficial effect of compounds present in
this plant in diseases, where these pro- and anti-
inflammatory cytokines are involved such as Multiple
Sclerosis, Rheumatoid Arthritis and Cancer. This anti-
inflammatory effect might result from the direct effect of
one or more of the identified compounds such as catechin
or caffeic acid or from a synergistic interaction between
different compounds present in our preparations, such as
tannins, sterols, and alkaloids; or from a single bio-active
molecule. At this point, our main focus is the identifica-
tion of the compound(s) underlying this effect.
Methods
Capparis Spinosa
Capparis Spinosa leaves were collected from the region
of Safi in Morocco (GPS coordination are 32°16 41N
and 90° 07 56W, altitude 146.4), between August and
September of 2013. It was identified by the help of a
plant biologist in Biology department of the polydisci-
plinary faculty of Safi. A voucher (No. 93664) of plant
specimen has been deposited in the herbarium of the
Botanical Department of the Scientific Institute of Rabat,
Morocco.
Capparis Spinosa preparations
Leaves were washed, air-dried then incubated in metha-
nol (Sigma, USA) for 48 h at room temperature. The
methanol extract was filtered then concentrated by ro-
tary evaporation. The obtained dried extract was divided
into 2 parts. The first part was dissolved in DMSO (crud
extract) (Sigma, USA) and the second part was dissolved
in distilled water and agitated vigorously several times,
filtered, concentrated using rotary evaporation and dis-
solved in distilled water (aqueous fraction). Crud extract
and aqueous fraction were both stored at −20 °C until
use.
Phytochemical analysis
Capparis Spinosa aqueous fraction and crud extract
were subjected to qualitative chemical screening for
identification of various classes of active chemical con-
stituents using a previously described method [56].
Screening was performed for Saponins, Tannins, Alkaloids,
Sterols, triterpenes and flavone aglycones.
Dosage of total phenolic compounds
Total phenols content in samples was determined by the
Folin-Ciocalteau colorimetric method [57]. Extract
(0.5 ml) was reacted with 2.5 ml of the Folin- Ciocalteau
diluted ten times in distilled water for 4 min. Then, 2 ml
of an aqueous solution of Na2CO3 (75 mg/ml) were
added to the reaction mixture. After 2 h incubation at
room temperature, the absorbance was measured at
760 nm. Gallic acid was used as a reference standard
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and total phenols content was expressed as mg gallic
acid equivalents per gram of plant extract (GAE/g of dry
weight). Experience was performed in triplicate.
Dosage of total flavonoid compounds
The flavonoid content was measured according to a pre-
viously reported colorimetric assay [58]. To design the
calibration curve, 1 ml of standard solution of quercetin
prepared at different concentrations (0–25 μg/ml) was
added to 1 ml of 2 % AlCl3 methanol solution. After in-
cubation for 60 min at room temperature, the absorb-
ance was read at 420 nm. The same reaction was applied
to extract at different concentration (0.1–0.5 μg/ml).
Total flavonoid content was expressed as mg quercetin
equivalent per gram of plant extract. Samples were ana-
lyzed in triplicate.
Antioxidant activity by DPPH radical scavenging test
In order to assess the antioxidant ability of the crud
extract, the DPPH (2,2-Diphenyl-1-picrylhydrazyl)
approach was used. This is based on the ability of
the sample to reduce free radicals of a given color,
which changes after the oxidation-reduction reaction.
A more pronounced change indicated a stronger
antioxidant activity. Quantification was performed by
spectrophotometry. DPPH in the presence of an
antioxidant lowers the carmine color intensity up to
very pale yellow. Data are presented as IC50, which
means the concentration of a sample that reduces
oxidation to half (50 %). The DPPH radical scaven-
ging activity was evaluated according to a previously
described method [59]. Ethanolic solution of extract
and DPPH (Sigma-Aldrich, Steinheim, Germany)
were mixed in tube (25 μl: 975 μl). Tests were per-
formed with different extract concentrations. After
30 min, measurement of the absorbance was per-
formed at 517 nm at room temperature. Negative
and positive controls were performed in the same
conditions with ethanolic DPPH solution and Ascor-
bic acid, respectively. Tests were carried out in trip-
licates. The inhibition percentage of DPPH radical
was calculated according to the following formula:
Scavenging effect % ¼ A1 – A0ð Þ = A0½   100;
Where A0 was the absorbance of the control without
extract and A1 was the absorbance of the sample. Sam-
ple concentration providing 50 % inhibition (IC50) was
obtained by plotting the inhibition percentage against
sample concentrations.
Polyphenol and flavonoid compounds analysis by HPLC
Qualitative analysis of standard phenolic compounds in
Capparis Spinosa extract was performed using a high
performance liquid chromatography (HPLC) type
JASCO PU-1580, equipped with a UV detector/Vis
type JASCO 875 UV and a data treatment station
Azur version 3.0.3.0. The extract was evaporated to
dryness at 40 °C and then taken up with a mixture
of distilled water - acetonitril (88–12 %). After vigor-
ous stirring, the mixtures were filtered by passing
the solution through nylon membrane Whattman.
Analysis conditions used were: Column: C18 (1.7 μm
2,1 × 150 mm), UV Wavelength: 285 nm, 1 ml/min,
Gradient elution program was set as water - aceto-
nitrile (88–12 %). The solution of the polyphenol
mixture: catechin, rutin, vanillin, vanillic acid, caffeic
acid, syringic acid, and ferulic acid was prepared by
dissolving 1–5 mg of each polyphenol in 1 ml of the
acetonitril - water 12 −88 %. The final solution was
filtered through a nylon membrane Whattman
0.22 μm.
PBMC preparation and cell culture
Venous fresh blood was collected from fifteen
healthy adult volunteers, aged between 18 and
45 years old, informed with written consent, among
the fifteen donors, five donors were used for each
type of assay, MTT, cell proliferation and RT-qPCR.
PBMCs were isolated by centrifugation on Ficoll-
histopaque (d = 1.077 g/ml) (Sigma, USA), at 900 g
for 25 min at 18–20 °C. Cells were then washed
three times in RPMI-1640 at 400 g for 15 min and
re-suspended in RPMI-1640 media (sigma, USA)
with L-glutamine, supplemented with 10 % heat
inactivated newborn calf serum (sigma, USA),
26.3 g/l penicillin and 4.2 g/l streptomycin. Cells
were counted using a hemocytometer and standard
Trypan blue exclusion method and observed under
microscopy. PBMCs were incubated at 37 °C with
5 % CO2 (Heracell 150i incubator CO2, thermo-
sciences, France), in plat culture with different doses
of plant extracts, with or without 5 μg/ml of phyto-
haemagglutinin (PHA; Sigma, USA). Tests were per-
formed in triplicates.
MTT assay
Cell viability was determined by the MTT (3-(4, 5
dimethylthiazol-2-yl)-2, 5 diphenyltetrazolium bromide)
test [60]. Cells were cultured at 37 °C with 5 % CO2,
in 96-well plates (Hiwaka, Japan) at a concentration
of 5.105 cells/ml, with various concentrations of the
plant extract, in the presence or absence of PHA for
96 h. Enzymatic activity of each well was determined
by MTT assay and compared to that of untreated
cells. MTT (5 mg/ml, Sigma, USA) was dissolved in
RPMI, filtered through a 0.2 μm filter and stored at -
20 °C. During the test, 20 μl of the MTT solution
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were added to each well and the corresponding plates
were incubated at 37 °C, for 4 h in a humidified at-
mosphere with 5 % CO2. Subsequently, the plates
were centrifuged at 800 g for 20 min, and 100 μl of
DMSO were then added to each well, and mixed
thoroughly to dissolve the crystals. High optical dens-
ity readings corresponded to a high intensity of color-
ation, which is due to viable cells able to metabolize
MTT salts. SDH enzymatic activity (%) was calculated
using the following formula:
% of SDH enzymatic activity
¼ OD test‐OD controlð Þ= OD control½   100:
Cell proliferation assay
PBMCs were incubated in 96 well plates at a concentra-
tion of 106 cells/ml. C.S. preparations were used at a
final concentration of 10, 100 and 500 μg/ml, with or
without PHA, in triplicate. PBMCs were labeled before
culture with 5,6-carboxyfluorescein diacetate succinimi-
dyl ester (CFSE) (Sigma, USA) at a concentration of
5 μM, according to a previous report [61]. Then, cells
were washed twice with RPMI containing 5 % heat
inactivated fetal calf serum. Cells were maintained in
culture at 37 °C and 5 % CO2 for four days. Fluorescence
measurements were performed using a FACS (BD
FACSCalibur Flow Cytometer, BD Biosciences, France)
and analyses were done using FlowJo software (Tree
Star, Inc. Ashland, USA). One hundred thousand events
were analyzed per sample.
Gene expression quantification by RT-qPCR
Total RNA isolation and Reverse Transcription (RT)
Total RNA was isolated by Trizol (Sigma, France) from
cells (106 cells/ml) cultured alone or with different doses
of C.S. preparations for 18 h in the presence or absence
of PHA. Isolated RNAs were diluted in DEPC Treated
Water (Invitrogene, France) and were measured with
spectrophotometer (NanoVue™ Plus Spectrophotometer
GE Healthcare UK Limited, UK). cDNA was synthesized
using M-MLV reverse transcriptase (Reverse Transcriptase
Super Scripte III, 10000 units, Invitrogene, France) from
0.5 μg total RNA, in a 20 μl reaction mixture according to
the manufacturer’s instructions, with 1 μl of oligo dT20
(50 μM) and 1 μl of dNTP (10 mM of each) added and
incubated at 65 °C for 5 min to break the secondary
structure of RNA. Then the mixture was chilled on ice for
at least 5 min. 4 μl of 5X Reverse Transcriptase buffer, 1 μl
of RNase Inhibitor (RNasin OUT 5000 units, Invitrogene,
France) and 1 μl of M-MLV reverse transcriptase
were added and incubated at 50 °C for 60 min, then
70 °C for 15 min.
Real-time qPCR assays
Relative quantification of gene expression was ana-
lyzed by real-time PCR using real time Fast 7500
(Applied Biosystems™). HPRT-1 was used as internal
control. Amplifications were performed using Sso-
Fast™ Eva Green® Supermix with Low ROX (BioRad,
France) as recommended by the manufacture man-
ual, in a 10 μl final volume, using primers at 500nM
for all genes. PCR was programmed as follows: 30 s
at 95 °C for polymerase activation and DNA sample
denaturation; then 40 cycles of 15 s at 95 °C and
30 s at 60 °C for annealing and extension. Each re-
action was performed in triplicate for each sample.
The primers used are described in Table 3. Fluores-
cence readings at the end of the extension phase of
each cycle were used to estimate the values for the
threshold cycles (Ct). The Ct values for each gene
were converted into relative quantification (2-ΔΔCt)
using machine 7500 Software v2.0.6 software. The
relative quantification for treated samples was calcu-
lated using cells with medium as a calibrator. PCR
negative control (with no template) was included for
each pair of primers.
Statistical analysis
All data were expressed as means with standard devia-
tions. Groups were compared using ANOVA-ONE way
followed by post Bonferroni’s Multiple Comparison test
and ANOVA-ONE way (Kruskal-Wallis test) flowed
by Dunn’s post test, with a level of significance set at
p < 0.05. Graphpad Prism 5.0 software was used for
all statistical analyses.
Table 3 Primers sequences used for qPCR
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